Emcure Pharmaceuticals Ltd. logo

Emcure Pharmaceuticals Ltd. (EMCURE)

Market Closed
10 Aug, 10:00
XNSE XNSE
1,995. 20
+16.8
+0.8492%
329.95B Market Cap
- P/E Ratio
- Div Yield
205,952 Volume
- Eps
1,978.4
Previous Close
Add Transaction
Day Range
1,967 2,048
Year Range
1,260 2,048
Want to track EMCURE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

EMCURE closed today higher at ₹1,995.2, an increase of 0.8492% from yesterday's close, completing a monthly increase of 8.671% or ₹159.2. Over the past 12 months, EMCURE stock gained 46.7059%.
The next announced payment will be in In 3 weeks on Sep 04, 2026 for a total of ₹3.6.
The last earnings report, released on May 21, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 1.24%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

EMCURE Chart

People also search for

Sun Pharmaceutical Industries Ltd.
1,944.4
-0.0308%
Tata Motors Ltd.
347.1
+0.0288%
Maruti Suzuki India Limited
14,097
+0.4274%
M&M
Mahindra & Mahindra Ltd.
3,517
+0.4283%
Bajaj Auto Limited
11,677
+0.1286%

Emcure Pharmaceuticals Ltd. (EMCURE) FAQ

What is the stock price today?

The current price is ₹1,995.20.

On which exchange is it traded?

Emcure Pharmaceuticals Ltd. is listed on XNSE.

What is its stock symbol?

The ticker symbol is EMCURE.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 329.95B.

Has Emcure Pharmaceuticals Ltd. ever had a stock split?

No, there has never been a stock split.

Emcure Pharmaceuticals Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Satish Ramanlal Mehta CEO
XNSE Exchange
Y228AJ107 CUSIP
IN Country
6,731 Employees
4 Sep 2026 Last Dividend
- Last Split
- IPO Date

Overview

Emcure Pharmaceuticals Limited is a globally recognized corporation dedicated to the development, manufacturing, and marketing of pharmaceutical products. With a comprehensive portfolio that spans multiple therapeutic areas, Emcure has established itself as a key player in the pharmaceutical industry since its inception in 1981. The company's headquarters are located in Pune, India, from where it orchestrates its worldwide operations. Emcure's mission is to improve patient care through the provision of innovative and effective pharmaceutical solutions, making critical contributions across a broad spectrum of healthcare needs.

Products and Services

  • Therapeutic Areas: Emcure offers a diverse range of products targeting various therapeutic needs such as gynecology, cardiovascular diseases, anti-infectives, HIV antivirals, respiratory disorders, gastrointestinal issues, pain and analgesics, blood-related conditions, oncology/anti-neoplastics, anti-diabetic treatments, hormones, neurology/central nervous system disorders, and more. This extensive product range reflects Emcure's commitment to addressing a wide spectrum of health concerns.
  • Vitamins, Minerals, and Nutrients: Beyond prescription medications, Emcure provides a variety of supplements designed to support overall health and well-being. These products aim to complement the therapeutic areas with preventive and nutritional support.
  • Product Development Platforms: Emcure stands out in the pharmaceutical industry for its investment in developing products across a variety of complex platforms. These include chiral molecules, complex Active Pharmaceutical Ingredients (APIs), orals, iron products, photochemistry products, liposomal and lyophilized injectables, high potency drugs, biotherapeutics, and novel drug delivery systems. This innovative approach ensures that Emcure remains at the forefront of pharmaceutical technology and therapy.
  • Brands: The company markets its diverse portfolio under several recognized brand names such as Orofer (focused on iron deficiency), Bevon (a range of multivitamins), Maxtra (cold and allergy treatments), Zostum (antibiotics), Metpure (blood pressure management), and Eslo (anti-hypertensive). These brands have become synonymous with quality and efficacy in their respective therapeutic areas.

Contact Information

Address: Plot No. P-1 and P-2, Pune, India, 411057
Phone: 91 20 3507 0033